Skip to main content
$29.80 $0.42 (1.4%)

04:00 PM EDT on 10/22/21

Supernus Pharmaceuticals (NASDAQ:SUPN)

CAPS Rating: 3 out of 5

Current Price $29.80 Mkt Cap $1.6B
Open $29.48 P/E Ratio 15.72
Prev. Close $29.80 Div. (Yield) $0.00 (0.0%)
Daily Range $29.31 - $30.01 Volume 301,217
52-Wk Range $17.20 - $34.29 Avg. Daily Vol. 403,145

Caps

How do you think NASDAQ:SUPN will perform against the market?

Add Stock to CAPS Watchlist

All Players

62 Outperform
12 Underperform
 

All-Star Players

8 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:SUPN Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

crashavoidance (99.01)
Submitted July 29, 2015

Already done well with this but believe still some good upside if the two drugs still in development pan out (so far looks good but longer term / higher risk play until actually happens)In the meantime, approach of adding ER (extended release) to… More

XMFBlacknGoldX (< 20)
Submitted June 29, 2012

Man, I wish I got in on this one just a few days earlier (IPO debut). Still, this is about as safe as a red thumb gets. Supernus has shareholders' equity of just $270,000 as of 1Q12, which registers as a fair book value of a whopping $0.0113 per… More

NASDAQ:SUPN VS S&P 500 (SPY)

Fools bullish on NASDAQ:SUPN are also bullish on:

Fools bearish on NASDAQ:SUPN are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about SUPN.

Recs

0
Member Avatar TMFjimhalley (22.94) Submitted: 3/21/2021 8:49:00 PM : Outperform Start Price: $25.49 NASDAQ:SUPN Score: +0.14

Supernus is already growing revenue and will really take off if the company's ADHD therapy candidate, SPN-812, is approved this year, as expected.

Recs

0
Member Avatar TMFacarchidi (< 20) Submitted: 3/1/2021 11:32:39 AM : Outperform Start Price: $26.08 NASDAQ:SUPN Score: -2.79

Undervalued; producing novel therapeutics for underserved disease areas.

Recs

0
Member Avatar Bigsef77 (69.68) Submitted: 4/29/2020 2:54:00 PM : Outperform Start Price: $48.20 NASDAQ:SUPN Score: -96.09

CNS portfolio acquisition

Leaderboard

Find the members with the highest scoring picks in SUPN.

Score Leader

efarev

efarev (37.42) Score: +319.09

The Score Leader is the player with the highest score across all their picks in SUPN.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
mstanphi 62.44 6/14/2012 8/8/2013 Outperform 3Y $5.22 +468.01% +240.27% +227.74 0 Comment
ptanabe 47.01 8/1/2013 Outperform 5Y $6.87 +331.59% +166.58% +165.01 1 Comment
MichaelHamilton 33.05 8/20/2013 Outperform 5Y $6.95 +326.62% +174.57% +152.05 0 Comment
davisbunn < 20 9/17/2014 Outperform 3Y $8.40 +252.98% +126.20% +126.77 0 Comment
MNGPHR 51.80 6/26/2012 Underperform 3W $13.23 +124.11% +245.05% +120.94 0 Comment
crashavoidance 99.01 1/13/2014 Outperform 5Y $8.03 +269.24% +149.71% +119.53 1 Comment
wilburn1121 < 20 1/12/2015 Outperform 1Y $8.74 +239.24% +121.69% +117.56 0 Comment
SweetT 34.27 1/6/2014 Outperform 5Y $8.19 +262.03% +146.99% +115.04 0 Comment
mirqce < 20 11/24/2014 Outperform NS $8.94 +231.66% +118.74% +112.92 1 Comment
Kilroy9376 35.48 1/22/2013 Outperform 5Y $7.35 +303.40% +205.50% +97.90 0 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for SUPN.